SYNTHESIS
Papers
506
1
H NMR (300 MHz, CDCl ): δ = 6.46 (t, J = 2.4 Hz, 1 H), 5.33 (t, J
Hz, 3 H), 0.95–0.82 (m, 12 H), 0.79 (d, J = 6.8 Hz, 3 H), 0.08 (s, 6 H).
3
13
= 7.8 Hz, 1 H), 4.32 (m, 1 H), 3.70 (t, J = 7.4 Hz, 1 H), 3.50 (m, 1 H),
2.97 (m, 1 H), 2.85–2.70 (m, 1 H), 2.32–2.27 (m, 1 H), 2.24–2.16 (m,
1 H), 1.90–1.77 (m, 3 H), 1.71–1.65 (m, 2 H), 1.64 (s, 3 H), 1.62–1.53
(m, 2 H), 1.46–1.32 (m, 4 H), 1.26–1.20 (m, 1 H), 1.01 (d, J = 7.4 Hz,
C NMR (75 MHz, CDCl ): δ = 203.3, 146.9, 145.0, 139.7, 122.7,
3
81.1, 58.5, 50.4, 47.5, 45.8, 45.1, 42.9, 41.9, 38.9, 36.6, 29.1, 28.8,
28.4, 25.8 (3 C), 23.0, 21.9, 19.1, 18.9, 18.1, 17.6, 12.2, –4.5, –4.8.
+
MS m/z (M ) calcd 470.3580, obsd 470.3581.
3 H), 0.91 (d, J = 6.8 Hz, 3 H), 0.87 (d, J = 6.8 Hz, 3 H), 0.77 (s, 3 H).
[α]D20 +167 (c = 1.11, CHCl ).
3
13
C NMR (75 MHz, CDCl ): δ = 205.6, 150.2, 139.9, 136.8, 124.9,
3
82.4, 46.9, 46.3, 46.0, 45.2, 44.6, 41.5, 40.8, 39.5, 36.3, 29.7, 27.0,
26.3, 24.5, 23.5, 21.9, 18.4, 17.0, 14.8.
MS m/z (M ) calcd 356.2715, obsd 356.2714.
(2S,3S,7aS,10S,10aS)-2-(tert-Butyldimethylsiloxy)-2,3,7,7a,8,9,
10,10a,11,11a-decahydro-10-isopropyl-3,6,7a-trimethylcyclopen-
ta[4,5]cyclooct[1,2-f]inden-12(1H)-one (42a) and (2S,3S,7aS,
10S,10aS)-2,3,7,7a,8,9,10,10a,11,11a-Decahydro-2-hydroxy-10-
isopropyl-3,6,7a-trimethylcyclopenta[4,5]cyclooct[1,2-f]inden-
12(1H)-one (42b):
SeO2 on silica gel (260 mg, 0.11 mmol) was suspended in CH2Cl2
(5 mL) and tert-butyl hydroperoxide (20 mg, 0.22 mmol) was added.
After 10 min, 36a (35 mg, 0.074 mmol) in CH2Cl2 (5 mL) was intro-
duced at r.t. and stirred for 72 h. The mixture was heated to reflux and
more SeO2 on silica gel was added. Products 42a (9.6 mg, 27%) and
42b (6.6 mg, 19%) were collected following chromatography on sili-
ca gel with elution by 2% Et2O in hexanes.
+
Anal. Calcd for C
9.98.
H O : C, 80.85; H, 10.18. Found: C, 81.22; H,
24 36 2
For 36b: heavy, colorless oil.
–1
IR (neat, cm ): ν = 3420, 2930, 2780, 1640, 1440, 1370.
1
H NMR (300 MHz, C D ): δ = 5.38 (t, J = 7.7 Hz, 1 H), 3.88–3.85
6
6
(m, 1 H), 3.61 (t, J = 6.0 Hz, 1 H), 3.13 (dd, J = 8.4, 8.6 Hz, 1 H), 2.85
(dd, J = 5.9, 10.7 Hz, 1 H), 2.66–2.48 (m, 3 H), 2.36 (d, J = 6.6 Hz, 1
H), 1.79–1.57 (m, 2 H), 1.58 (s, 3 H), 1.56–1.03 (m, 9 H), 0.98 (d, J
= 7.3 Hz, 3 H), 0.93–0.82 (m, 1 H), 0.78 (d, J = 6.8 Hz, 3 H), 0.73 (d,
J = 6.8 Hz, 3 H), 0.70 (s, 3 H).
Rhodium Trichloride-Promoted Isomerizations.
Method A: To a solution of 35a (91 mg, 0.19 mmol) in EtOH (30 mL)
was added RhCl · 3H O (14 mg, 0.054 mmol) and the orange mix-
ture was heated to reflux for 20 h. The residue was purified by chro-
matography on silica gel with 30% EtOAc in hexanes to give 24 mg
(35%) of 36a.
For 42a: white solid, mp 160°C (dec).
–1
IR (neat, cm ): ν = 1680, 1510, 1410, 1300, 1150.
3
2
1
H NMR (300 MHz, CDCl ): δ = 6.35 (d, J = 12.3 Hz, 1 H), 6.05 (d,
3
J = 12.3 Hz, 1 H), 3.85 (m, 1 H), 3.37 (dd, J = 6.2, 17.1 Hz, 1 H), 3.10
(d, J = 5.8 Hz, 1 H), 2.89 (dd, J = 4.1, 17.1 Hz, 1 H), 2.79 (m, 1 H),
2.62 (d, J = 14 Hz, 1 H), 2.51 (td, J = 4.2, 12.4 Hz, 1 H), 2.36 (dd, J
= 12.9, 4.0 Hz, 1 H), 1.92 (m, 1 H), 1.75 (br d, J = 12.7 Hz, 2 H), 1.62
(s, 3 H), 1.57–1.22 (m, 4 H), 1.39 (s, 1 H), 1.19 (d, J = 6.7 Hz, 3 H),
1.19 (s, 1 H), 1.14 (d, J = 6.8 Hz, 3 H), 1.06 (d, J =7.2 Hz, 3 H), 0.92
Method B: A solution of 35b (7.7 mg, 0.022 mmol) in EtOH (10 mL)
was treated with rhodium trichloride (4.6 mg, 0.022 mmol) and the
solution was heated to reflux for 17 h. The EtOH was removed and
the residue was placed atop a column of silica gel and eluted with
20–25% EtOAc in hexanes to deliver 3 mg (35%) of 36b.
(s, 9 H), 0.78 (s, 3 H), 0.04 (s, 3 H), 0.02 (s, 3 H).
13
C NMR (75 MHz, CDCl ): δ = 192.4, 148.6, 143.6, 138.4, 137.3,
3
131.1, 123.1, 77.4, 55.9, 49.1, 47.2, 46.1, 43.0, 42.1, 42.0, 38.6, 30.2,
26.1, 26.0 (3 C), 24.3, 22.0, 18.5, 18.2, 18.0, 17.9, 16.3, –4.4, –4.6.
MS m/z (M ) calcd 468.3424, obsd 468.3420.
(2S,3S,6aS,7aR,10S,10aS)-2-(tert-Butyldimethylsiloxy)-
2,3,6a,7,7a,8,9,10,10a,11,11a,12a-dodecahydro-10-isopropyl-
3,6,7a-trimethylcyclopenta[4,5]cyclooct[1,2-f]inden-12(1H)-one
(40):
+
For 42b: white solid, mp 158–159°C.
–1
IR (neat, cm ): ν = 3390, 2950, 1640, 1440, 1370, 1200.
1
Ketone 36a (4.3 mg, 9.1 mmol) was dissolved in a solution of K CO
H NMR (300 MHz, C D ): δ = 6.29 (d, J = 12.4 Hz, 1 H), 5.94 (d, J
2
3
6 6
(3 mg) in MeOH (3 mL) and THF (0.5 mL) and stirred for 48 h. The
mixture was concentrated, CH2Cl2 (10 mL) was added, and the organ-
ic solution was dried, filtered, and evaporated. The residue was puri-
fied on silica gel with elution by 1.5% Et2O in hexanes to furnish 40
= 12.4 Hz, 1 H), 3.54 (m, 1 H), 3.18 (dd, J = 5.7, 17.8 Hz, 1 H), 3.00
(d, J = 5.9 Hz, 1 H), 2.74 (d, J = 17.9 Hz, 1 H), 2.58 (m, 2 H),
2.50–2.40 (m, 1 H), 2.28 (m, 1 H), 1.87 (m, 1 H), 1.75–1.64 (m, 3 H),
1.58 (s, 3 H), 1.56–1.14 (m, 4 H), 1.12 (d, J = 6.8 Hz, 3 H), 1.13 (s, 1
H), 1.08 (d, J = 6.8 Hz, 3 H), 0.87 (d, J = 7.3 Hz, 3 H), 0.72 (s, 3 H).
(2.5 mg, 58%) as a white solid, mp 110–127°C.
1
13
H NMR (300 MHz, CDCl ): δ = 6.06 (t, J = 10.6 Hz, 1 H), 5.85 (m,
C NMR (75 MHz, C D ): δ = 192.5, 149.4, 143.2, 138.3, 137.3,
3
6 6
1 H), 3.91–3.88 (m, 1 H), 3.28 (dd, J = 0.5, 4.9 Hz, 1 H), 3.02 (dd, J
= 6.2, 8.0 Hz, 1 H), 2.77 (m, 1 H), 2.45 (dd, J = 9.0, 1.4 Hz, 1 H),
2.25–2.15 (m, 1 H), 2.12–2.05 (m, 1 H), 1.96–1.90 (m, 1 H),
1.80–1.10 (m, 10 H), 1.01 (d, J = 7.3 Hz, 3 H), 0.99–0.80 (m, 18 H),
0.75 (s, 3 H), 0.07 (s, 6 H).
131.0, 123.5, 75.3, 56.2, 49.2, 46.2, 43.0, 42.5, 42.1, 38.6, 30.2, 26.1,
24.3, 22.0, 18.6, 18.0, 17.9, 16.6.
MS m/z (M ) calcd 354.2559, obsd 354.2577.
+
13C NMR (75 MHz, CDCl ): δ = 205.1, 149.7, 145.8, 137.2, 124.7,
3
(2S,3S,3aR,6aS,7aR,10S,10aS,11aR,12S,12aS)-2-(tert-Butyldime-
thylsiloxy)-1,2,3,3a,4,6a,7,7a,8,9,10,10a,11,11a,12,12a-hexa-
decahydro-10-isopropyl-3,6,7a,12-tetramethylcyclopenta[4,5]-
cyclooct-[1,2-f]inden-12-ol (43):
53.9, 50.1, 46.2, 45.5, 45.0, 41.6, 41.4, 40.3, 39.0, 36.8, 29.0, 27.0,
25.9 (3 C), 23.1, 22.0, 18.6, 18.2, 17.8, 17.7, 16.8, –4.5, –4.8.
+
MS m/z (M ) calcd 470.3580, obsd 470.3590.
Ketone 34a (20 mg, 0.042 mmol) was dissolved in THF (5 mL) at 0°C
before MeLi (36.4 µL, 0.051 mmol) was added via syringe. The mix-
ture was stirred at 20°C for 30 min and quenched with brine (3 mL).
The separated organic phase was dried and concentrated. The crude
material was purified by chromatography on silica gel with 5%
EtOAc in hexanes to give 43 (21 mg, 99%) as a colorless oil.
(+)-(2R,3S,3aR,6aS,7aR,10S,10aS,11aS)-2-(tert-Butyldimethyl-
siloxy)-3,3a,4,6a,7,7a,8,9,10,10a,11,11a-dodecahydro-10-isopro-
pyl-3,6,7a-trimethylcyclopenta[4,5]cyclooct[1,2-f]inden-12(2H)-
one (41):
Ketone 35a (28 mg, 59 mmol) was dissolved in MeOH (10 mL),
K CO (5 mg) was added, and the suspension was stirred for 12 h at
–1
IR (neat, cm ): ν = 3320, 1470, 1370, 1260, 1090.
2
3
1
r.t. After an additional 12 h at 60°C, the MeOH was removed and
CH2Cl2 (3 mL) was added. The mixture was dried and concentrated,
and the residue was purified by chromatography on silica gel with
1.5% Et2O in hexanes to furnish 41 (15 mg, 53%) as a white solid, mp
H NMR (300 MHz, CDCl ): δ = 7.06 (br s, 1 H), 5.41 (br s, 1 H),
3
4.18–4.13 (m, 1 H), 3.84–3.73 (m, 1 H), 3.22 (br s, 1 H), 2.97–2.91
(m, 1 H), 2.56–2.04 (m, 4 H), 2.00–1.87 (m, 2 H), 1.83 (s, 3 H),
1.75–1.25 (m, 14 H), 1.05 (s, 3 H), 0.95 (d, J = 6.8 Hz, 3 H), 0.91 (s,
95–110°C.
3 H), 0.89 (s, 9 H), 0.81 (d, J = 6.8 Hz, 3 H), 0.04 (s, 6 H).
1
13
H NMR (300 MHz, CDCl ): δ = 6.58 (s, 1 H), 5.16 (br d, J = 7.2 Hz,
C NMR (75 MHz, CDCl ): δ = 141.4, 127.0, 85.2, 78.5, 76.8, 76.4,
3
3
1 H), 4.46 (d, J = 8.2 Hz, 1 H), 3.75–3.67 (m, 1 H), 3.45 (t, J = 3.3 Hz,
1 H), 2.48–2.25 (m, 3 H), 2.00–1.85 (m, 1 H), 1.80–1.60 (m, 4 H),
1.56 (s, 4 H), 1.52–1.30 (m, 4 H), 1.30–1.13 (m, 5 H), 1.10 (d, J = 7.0
52.5, 48.9, 48.4, 44.1, 41.7, 39.6, 39.1, 35.8, 31.6, 29.4, 28.1, 25.9 (3
C), 25.3, 24.5, 24.4, 23.9, 21.9, 18.2, 18.1, 13.4, –4.4, –4.7.
MS m/z (M ) calcd 488.4050, obsd 488.4047.
+